A.C.P. 10 ANAESTHETIC PREMEDICATION, TRANQUILLISER AND TRAVEL SICKNESS STERILE INJECTION Avustralya - İngilizce - APVMA (Australian Pesticides and Veterinary Medicines Authority)

a.c.p. 10 anaesthetic premedication, tranquilliser and travel sickness sterile injection

ceva animal health pty ltd - acepromazine maleate - parenteral liquid/solution/suspension - acepromazine maleate thiazole active 13.5 mg/ml - central nervous system - cattle | horse | pigs | sheep | beef | boar | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | colt | cow | - anaesthetic - local/general | general anaesthetic | immobiliser | local anaesthetic | premedication | sedative | tranquilliser | travel sickness

Koagulon Vitamin K1 Injection Yeni Zelanda - İngilizce - Ministry for Primary Industries

koagulon vitamin k1 injection

international animal health products pty ltd - vitamin k1 - vitamin k1 10 g/litre - antidote

Abinex Forte 1 % w/v Pour On Solution İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

abinex forte 1 % w/v pour on solution

bimeda animal health limited - abamectin - pour-on solution - 1 percent weight/volume - abamectin

Procillin 300 mg/ml Suspension for Injection for Cattle, Sheep and Pigs İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

procillin 300 mg/ml suspension for injection for cattle, sheep and pigs

bimeda animal health limited - procaine benzylpenicillin - suspension for injection - 300 milligram(s)/millilitre - procaine benzylpenicillin

MARKS-MIN SE B12 INJECTABLE FOR CATTLE & SHEEP Avustralya - İngilizce - APVMA (Australian Pesticides and Veterinary Medicines Authority)

marks-min se b12 injectable for cattle & sheep

boehringer ingelheim animal health australia pty. ltd. - selenium as sodium selenite; cyanocobalamin (vitamin b12) - parenteral liquid/solution/suspension - selenium as sodium selenite mineral-selenium active 3.3 g/l; cyanocobalamin (vitamin b12) vitamin-b12 active 1.4 g/l - nutrition & metabolism

CCD TILMICOSIN 200 PREMIX Avustralya - İngilizce - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ccd tilmicosin 200 premix

ccd animal health pty ltd - tilmicosin phosphate - oral powder, pre-mix - tilmicosin phosphate antibiotic active 200.0 g/kg - antibiotic & related - pigs | boar | gilt | piglet | sow | swine - pneumonia | bacterial pneumonia

SULECTIM PLUS BOLUS Kanada - İngilizce - Health Canada

sulectim plus bolus

remedy animal health products ltd - sodium chloride; magnesium oxide; calcium carbonate; streptomycin (streptomycin sulfate); neomycin (neomycin sulfate); sulfamethazine; sulfamerazine; sulfathiazole (sulfathiazole sodium); sulfanilamide; vitamin a; vitamin d; vitamin k (menadione sodium bisulfite); potassium acetate; sodium acetate - bolus - 345mg; 8mg; 14mg; 100mg; 100mg; 500mg; 500mg; 1000mg; 500mg; 10000unit; 2000unit; 10mg; 62.5mg; 380mg - sodium chloride 345mg; magnesium oxide 8mg; calcium carbonate 14mg; streptomycin (streptomycin sulfate) 100mg; neomycin (neomycin sulfate) 100mg; sulfamethazine 500mg; sulfamerazine 500mg; sulfathiazole (sulfathiazole sodium) 1000mg; sulfanilamide 500mg; vitamin a 10000unit; vitamin d 2000unit; vitamin k (menadione sodium bisulfite) 10mg; potassium acetate 62.5mg; sodium acetate 380mg - cattle

ENALAPRIL GENERIC HEALTH enalapril maleate 20mg tablet blister pack Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

enalapril generic health enalapril maleate 20mg tablet blister pack

generic health pty ltd - enalapril maleate, quantity: 20 mg - tablet, uncoated - excipient ingredients: hypromellose; lactose monohydrate; iron oxide red; maleic acid; zinc stearate; iron oxide yellow; maize starch - hypertension. enalapril generic health is indicated in the treatment of: all grades of essential hypertension; renovascular hypertension. congestive heart failure. enalapril generic health is indicated in the treatment of all degrees of symptomatic heart failure. in such patients it is recommended that enalapril be administered together with a diuretic. left ventricular dysfunction. all degrees of left ventricular dysfunction where the left ventricular ejection fraction is less than 35%, irrespective of the presence or severity of obvious symptoms of heart failure.

ENALAPRIL GENERIC HEALTH enalapril maleate 10mg tablet blister pack Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

enalapril generic health enalapril maleate 10mg tablet blister pack

generic health pty ltd - enalapril maleate, quantity: 10 mg - tablet, uncoated - excipient ingredients: hypromellose; maleic acid; iron oxide red; zinc stearate; maize starch; lactose monohydrate - hypertension. enalapril generic health is indicated in the treatment of: all grades of essential hypertension; renovascular hypertension. congestive heart failure. enalapril generic health is indicated in the treatment of all degrees of symptomatic heart failure. in such patients it is recommended that enalapril be administered together with a diuretic. left ventricular dysfunction. all degrees of left ventricular dysfunction where the left ventricular ejection fraction is less than 35%, irrespective of the presence or severity of obvious symptoms of heart failure.

ENALAPRIL GENERIC HEALTH enalapril maleate 5mg tablet blister pack Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

enalapril generic health enalapril maleate 5mg tablet blister pack

generic health pty ltd - enalapril maleate, quantity: 5 mg - tablet, uncoated - excipient ingredients: maleic acid; zinc stearate; maize starch; hypromellose; lactose monohydrate - hypertension. enalapril generic health is indicated in the treatment of: all grades of essential hypertension; renovascular hypertension. congestive heart failure. enalapril generic health is indicated in the treatment of all degrees of symptomatic heart failure. in such patients it is recommended that enalapril be administered together with a diuretic. left ventricular dysfunction. all degrees of left ventricular dysfunction where the left ventricular ejection fraction is less than 35%, irrespective of the presence or severity of obvious symptoms of heart failure.